Search Results 311-320 of 17608 for Glucocorticoids

1. A Blood Collection Protocol to Study the Immune Responses of Cancer Patients with Malignancies - Mayo Clinic

   Chronic doses of glucocorticoids more than twice physiologic (e.g., daily prednisone or prednisolone >10 mg daily, hydrocortisone >40 mg daily, or dexamethasone ...

2. A Study To Evaluate Avacopan In Participants With ANCA-associated Vasculitis - Mayo Clinic

   Have been taking an oral daily dose of a glucocorticoid of more than 10 mg prednisone equivalent for more than 6 weeks continuously before signing of the ...

3. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

   Use of systemic glucocorticoids (excluding topical or ophthalmic applications or inhaled forms) for more than 10 consecutive days within 90 days prior to ...

4. Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk Myelodysplastic Syndromes - Mayo Clinic

   ... glucocorticoids, etc., must be concluded 1 month prior to study treatment. Diagnosis of CMML. Poor medical risk because of other conditions such as ...

5. Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/​Refractory T-cell Non-Hodgkin Lymphoma - Mayo Clinic

   ... glucocorticoids, mitotane, modafinil, nevirapine, oxcarbazepine, phenobarbital, phenytoin, pioglitazone, rifabutin, rifampin, troglitazone as well as the ...

6. A Study of to Evaluate Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer - Mayo Clinic

   ... glucocorticoids, progesterone, rifampin, phenobarbital, St. John's wort). Any condition that impairs the ability to swallow or absorb oral medication (e.g. ...

7. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

   Glucocorticoids (e.g., oral cortisone, hydrocortisone, prednisone, methylprednisolone, or dexamethasone). Daily oral dexamethasone ≤ 1.5 mg (or equivalent) ...

8. https://www.mayoclinic.org/spanish_organization_concepts.xml

9. Publications - Amer N. Kalaaji, M.D. - Mayo Clinic

   Glucocorticoid-induced osteoporosis in dermatologic practice: a review. J Drugs Dermatol. 2008 Nov; 7(11):1053-9. View PubMed; Passe AM, Davis MD, Kalaaji AN ...

10. Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis

    Prior or current systemic treatment with DMARDs, immunomodulatory agents, or glucocorticoids for IA or other rheumatic or immunologic diseases. Tetracycline ...